HDE supplement

H010002 S009: OP-1 IMPLANT

FDA HDE supplement · 30-day notice · OLYMPUS BIOTECH CORPORATION

Key facts

Original HDE H010002
Supplement number S009
Supplement type 30-day notice
Reason for the supplement process change - manufacturer/sterilizer/packager/supplier
Trade name OP-1 IMPLANT
Generic name Filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction
Applicant OLYMPUS BIOTECH CORPORATION
Product code MPW
Received date Aug 18, 2003
Decision date Sep 16, 2003
Docket number 01M-0482

At a glance

  • No Approval order on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About HDE supplements

An HDE supplement asks FDA to approve a change to a Humanitarian Use Device that already holds a humanitarian device exemption.

Source: U.S. Food and Drug Administration (FDA), Humanitarian Device Exemption (HDE) database · Source date:

Browse all HDE supplements